Noriaki Sato Selected Research

sorivudine

1/2020

Viral ribonucleotide reductase attenuates the anti-herpes activity of acyclovir in contrast to amenamevir.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Noriaki Sato Research Topics

Disease

3	Inflammation (Inflammations) 01/2022 - 04/2015
2	Infections 01/2020 - 01/2019
2	Heart Failure 12/2013 - 09/2012
1	Obesity 10/2022
1	Esophageal Neoplasms (Esophageal Cancer) 04/2022
1	Thrombosis (Thrombus) 04/2022
1	Neoplasms (Cancer) 04/2022
1	COVID-19 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Human Influenza (Influenza) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	IGA Glomerulonephritis (IGA Nephropathy) 09/2021
1	Diabetes Mellitus 03/2021
1	Hypertension (High Blood Pressure) 03/2021
1	Chronic Renal Insufficiency 01/2021
1	Herpes Genitalis (Genital Herpes) 01/2020
1	Herpes Zoster 01/2020
1	Sclerosis 01/2020
1	Cytomegalovirus Infections (Inclusion Disease) 01/2019
1	Vasculitis (Vasculitides) 05/2017
1	Microscopic Polyangiitis 05/2017
1	Glomerulonephritis 05/2017
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 05/2017
1	Atrial Fibrillation 09/2013
1	Left Ventricular Dysfunction 09/2012

Drug/Important Bio-Agent (IBA)

1	Amylases FDA Link 10/2022
1	Fluorouracil (Carac)FDA LinkGeneric 04/2022
1	Cisplatin (Platino)FDA LinkGeneric 04/2022
1	RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA 01/2022
1	favipiravirIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 09/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 09/2021
1	Pharmaceutical PreparationsIBA 03/2021
1	sorivudineIBA 01/2020
1	ASP2151IBA 01/2020
1	Acyclovir (Aciclovir)FDA LinkGeneric 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2020
1	Methenamine (Hexamine)IBA 01/2020
1	Periodic AcidIBA 01/2020
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2020
1	Foscarnet FDA LinkGeneric 01/2020
1	DNA Primase (Primase)IBA 01/2020
1	TOR Serine-Threonine KinasesIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Everolimus FDA Link 01/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2017
1	AntibodiesIBA 05/2017
1	antiglomerular basement membrane antibodyIBA 05/2017
1	Myeloblastin (Proteinase 3)IBA 05/2017
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 05/2017
1	Immunoglobulin G (IgG)IBA 05/2017
1	Peroxidase (Myeloperoxidase)IBA 05/2017
1	GlucocorticoidsIBA 05/2017
1	Pravastatin (Pravachol)FDA LinkGeneric 04/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2015
1	pitavastatin (itavastatin)FDA Link 04/2015

Therapy/Procedure

5	Therapeutics 01/2022 - 05/2017
2	Cardiac Rehabilitation 12/2013 - 09/2012
1	Neoadjuvant Therapy 04/2022
1	Drug Therapy (Chemotherapy) 04/2022
1	Thrombectomy 04/2022
1	Remission Induction 05/2017
1	Plasma Exchange 05/2017
1	Catheter Ablation 09/2013